Using 360° Virtual Reality Movies to Reduce Fear and Anxiety in Cancer Patients
The Effect of 360° Virtual Reality Movies on Fear and Anxiety
This study tests if watching 360° Virtual Reality movies can help reduce fear and anxiety in cancer patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 600 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Maastricht Radiation Oncology Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Maastricht) |
| Trial ID | NCT06199050 on ClinicalTrials.gov |
What this trial studies
This study evaluates the impact of web-based 360° Virtual Reality movies on reducing fear and anxiety in patients diagnosed with various types of cancer, including breast, lung, prostate, and head and neck cancers. The approach involves utilizing questionnaires to quantitatively assess patients' perceived levels of fear and anxiety before and after exposure to the VR content. The VR movies have been developed based on extensive discussions with healthcare professionals and are designed to address specific fears associated with cancer treatment. The implementation of these VR movies aims to enhance the patient care pathway by integrating innovative technology into clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who have been diagnosed with breast, lung, prostate, or head and neck cancer and can communicate in Dutch.
Not a fit: Patients currently undergoing radiotherapy treatment or those who have previously viewed the VR videos may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly alleviate fear and anxiety in cancer patients, improving their overall treatment experience.
How similar studies have performed: While the use of virtual reality in healthcare is gaining traction, this specific application for cancer-related fear and anxiety is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with breast- (only VMDIP), lung-, prostate-, head and neck cancer, a brain tumor. * Age 18+ * Being able to speak, read and write in Dutch * General interview between radiation oncologist and patient (= Intake) * Ability to give written informed consent before the start of the study * Decision talk about start of treatment must have taken place Exclusion Criteria: * Patients who are already receiving radiotherapy treatment * Pre-operative consultation for breast cancer patients * Patients who have seen the VR-videos already
Where this trial is running
Maastricht
- Maastricht Radiation Oncology — Maastricht, Netherlands (Recruiting)
Study contacts
- Principal investigator: Maria Jacobs — Maastro
- Study coordinator: Chiara Coleman
- Email: chiara.coleman@maastro.nl
- Phone: +31 88 44 55 707
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.